NCT01400906View on ClinicalTrials.gov

Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 20, 2011

Primary Completion Date

December 1, 2012

Study Completion Date

December 12, 2012

Conditions
Asthma
Interventions
DRUG

100 micrograms Fluticasone propionate

100 micrograms micronized drug blended with lactose in dry powder inhalator

DRUG

500 micrograms Fluticasone propionate

500 micrograms micronized drug blended with lactose in dry powder inhalator

DRUG

lactose powder

lactose powder in dry powder device : placebo comparator

Trial Locations (2)

1020

GSK Investigational Site, Brussels

NW10 7EW

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01400906 - Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics. | Biotech Hunter | Biotech Hunter